Plany Synektika. Nowe rynki, wzrost wyników, dywidenda, przejęcia

Dariusz Korecki, Vice President of Synektik, was a guest of Dariusz Wieczorek on the program "Straight from the Park." #STROSTOzPARKIETU Synektik, a supplier of medical devices, including da Vinci surgical robots, and a manufacturer of radiopharmaceuticals, continues to positively surprise. It is improving its financial results and is a star on the Warsaw Stock Exchange. Since the beginning of 2023, its share price has increased by over 900%. In mid-June, it reached a historic high of PLN 319. This year, Synektik successfully spun off a portion of its business, including assets related to a cardiotracer and a research project, to Syn2bio, which has been listed on the Warsaw Stock Exchange for over two months. What are Synektik's plans? What will drive further growth in the company's business? What are the prospects for surgical robotics? How does it view new markets, including Ukraine? Will it pay high dividends? Is it considering acquisitions? #PROSTOzPARKIETU More at: http://parkiet.com Twitter:   / parkietcom   Facebook:   / gazetaparkiet   Linkedin:   / parkiet